On this page
Back to topSeaport Therapeutics SPTX
Seaport Therapeutics listed on Nasdaq on 1 May 2026 and is not in the S&P 500. It is worth $981 million. 11 directors have filed with the SEC in the last 12 months (who counts), 1 of them an executive. 4 other officers are on file. At 30 Jun 2026, Arch Venture Management was its largest institutional holder, with 11.8% of the company.
- CEO
- Daphne Zohar
- Listed
- 1 May 2026 on Nasdaq, IPO filings and terms
- Headquarters
- Boston, MA
- Market cap
- $981M
- 19 Nov 2026 close
- Revenue
- -
- No annual report yet
Board and leadership
Board and officers
1 person here also holds roles at other S&P 500 companies.
Roles filed up to 30 Sep 2026
| Name | Title |
|---|---|
| Directors (11) | |
| Daphne ZoharChief Executive Officer | |
| Atlantic (Lux) S.a R.L. GeneralDirector | |
| Atlantic GenPar (Lux) SCSp GeneralDirector | |
| James HealyDirector | |
| Robert J. HombachDirector | |
| Sharon MatesDirector | |
| Steven M. PaulDirector | |
| Sandra E. PetersonDirectorAlso at Microsoft | |
| Jason PittsDirector | |
| Denice TorresDirector | |
| David E. WheadonDirector | |
| Officers (4) | |
| Lauren WhiteChief Financial OfficerLast filed 4 May 2026 | |
| Michael Cunyuan ChenChief Scientific OfficerLast filed 4 May 2026 | |
| Lana GladsteinGeneral CounselLast filed 4 May 2026 | |
| Antony LoebelChief Medical OfficerLast filed 4 May 2026 | |
Owners and trading
Largest institutional holders
Each fund group's share of Seaport Therapeutics. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 19 Nov 2025 to 19 Nov 2026
Directors and officers made no open-market sales and bought $335,120 in 2 purchases in the 12 months to 19 Nov 2026.
| Date | Person | Value |
|---|---|---|
| 3 Nov 2026Buy | Denice TorresDirector | $99K |
| 22 Jun 2026Buy | Robert J. HombachDirector | $236K |
Not on file: no weekly market cap history, no trades disclosed by members of Congress or officials since November 2023, no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet, no earnings release figures from the last six months, no quarterly results in its SEC XBRL filings and no director or officer changes, WARN notices or large insider sales in the last two years.